Evidence map›Paper›PMID 33511876›Full record

ArticleGlobal spine journal2022

Costs Associated With Timely and Delayed Surgical Treatment of Spinal Metastases.

Floris R van Tol, Julie R A Massier, Geert W J Frederix, F Cumhur Öner, Helena M Verkooijen, Jorrit-Jan Verlaan

Open access · goldAbstract read
In one paragraph

Article in Global spine journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Regional variability and economic impact on surgical practices for metastatic spinal disease in Europe - a survey on spine surgeons.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Answer to the Letter to the Editor of K. Huang concerning "The importance of timely treatment for quality of life and survival in patients with symptomatic spinal metastases" by van Tol FR, et al. [Eur Spine J (2020): DOI 10.1007/s00586-020-06599-x].European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Floris R van TolDepartment of Orthopedics, 569621University Medical Center Utrecht, the Netherlands.ORCID 0000-0003-4703-8885
Julie R A MassierDepartment of Orthopedics, 569621University Medical Center Utrecht, the Netherlands.
Geert W J FrederixJulius Center for Health Sciences and Primary Care, 569621University Medical Center Utrecht, the Netherlands.
F Cumhur ÖnerDepartment of Orthopedics, 569621University Medical Center Utrecht, the Netherlands.
Helena M VerkooijenImaging Division, 569621University Medical Center Utrecht, the Netherlands.
Jorrit-Jan VerlaanDepartment of Orthopedics, 569621University Medical Center Utrecht, the Netherlands.
University Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

STUDY

designRetrospective cohort study.

objectivesSymptoms caused by spinal metastases are often difficult to distinguish from symptoms caused by non-malignant spinal disease, complicating timely diagnosis, referral and treatment. The ensuing delays may promote the risk of neurological deficits or severe mechanical instability and consequent emergency surgery, leading to poorer prognosis. Presumably, treatment delay may subsequently lead to more health-care consumption and therefore increased average costs of treatment.

methodsAll patients surgically treated for spinal metastases were included in the current study. Based on the presence of alarming symptoms and urgency of the required intervention, patients were categorized as having received timely or delayed treatment. Pre-surgical, in-hospital, aftercare and total costs were analyzed and compared between the 2 groups.

resultsIn total, 299 patients were included, of which 205 underwent timely and 94 delayed treatment. There was no significant difference in pre-surigcal costs (€3.229,13 in the timely treated group

conclusionsThe total costs for timely treated patients with spinal metastases are significantly lower compared with patients receiving delayed treatment. Investing in the optimization of referral patterns may therefore reduce the overall pretreatment delay and subsequently increase patient outcome, leading to better clinical outcomes at lower costs.

Indexed as

metastasestumortumors

Identifiers

PMID33511876
PMCPMC9609516
OpenAlexW3122133130

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.